Xu Y - Search Results

1

Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.

Singh AB, Dong B, Kraemer FB, Xu Y, Zhang Y, Liu J. Singh AB, et al. Among authors: xu y. Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2448-2459. doi: 10.1161/ATVBAHA.118.311122. Arterioscler Thromb Vasc Biol. 2018. PMID: 30354208 Free PMC article.

2

Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr ^-/- mice.

Xu J, Xu Y, Xu Y, Yin L, Zhang Y. Xu J, et al. Among authors: xu y. Sci Rep. 2017 Dec 19;7(1):17845. doi: 10.1038/s41598-017-18232-x. Sci Rep. 2017. PMID: 29259301 Free PMC article.

3

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.

Jadhav K, Xu Y, Xu Y, Li Y, Xu J, Zhu Y, Adorini L, Lee YK, Kasumov T, Yin L, Zhang Y. Jadhav K, et al. Among authors: xu y, xu j. Mol Metab. 2018 Mar;9:131-140. doi: 10.1016/j.molmet.2018.01.005. Epub 2018 Jan 11. Mol Metab. 2018. PMID: 29361497 Free PMC article.

4

Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.

Singh AB, Dong B, Xu Y, Zhang Y, Liu J. Singh AB, et al. Among authors: xu y. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):358-371. doi: 10.1016/j.bbalip.2018.12.012. Epub 2018 Dec 20. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 30580099 Free PMC article.

5

Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.

Xu Y, Zhu Y, Jadhav K, Li Y, Sun H, Yin L, Kasumov T, Chen X, Zhang Y. Xu Y, et al. Hepatol Commun. 2019 Mar 25;3(6):763-775. doi: 10.1002/hep4.1341. eCollection 2019 Jun. Hepatol Commun. 2019. PMID: 31168511 Free PMC article.

6

Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.

Li Y, Xu Y, Jadhav K, Zhu Y, Yin L, Zhang Y. Li Y, et al. Among authors: xu y. Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1574-1587. doi: 10.1161/ATVBAHA.119.312610. Epub 2019 Jul 11. Arterioscler Thromb Vasc Biol. 2019. PMID: 31291759 Free PMC article.

7

Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis.

Xu Y, Xu Y, Zhu Y, Sun H, Juguilon C, Li F, Fan D, Yin L, Zhang Y. Xu Y, et al. Mol Ther. 2020 Jan 8;28(1):202-216. doi: 10.1016/j.ymthe.2019.09.008. Epub 2019 Sep 12. Mol Ther. 2020. PMID: 31604677 Free PMC article.

8

Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice.

Xu Y, Zhu Y, Bawa FC, Hu S, Pan X, Yin L, Zhang Y. Xu Y, et al. Hepatol Commun. 2020 Feb 20;4(4):527-539. doi: 10.1002/hep4.1487. eCollection 2020 Apr. Hepatol Commun. 2020. PMID: 32258948 Free PMC article.

9

Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).

Xu Y, Zhu Y, Hu S, Xu Y, Stroup D, Pan X, Bawa FC, Chen S, Gopoju R, Yin L, Zhang Y. Xu Y, et al. Hepatology. 2021 Jun;73(6):2251-2265. doi: 10.1002/hep.31604. Epub 2021 May 14. Hepatology. 2021. PMID: 33098092 Free PMC article.

10

Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice.

Xu Y, Pan X, Hu S, Zhu Y, Cassim Bawa F, Li Y, Yin L, Zhang Y. Xu Y, et al. Am J Physiol Gastrointest Liver Physiol. 2021 Jan 1;320(2):G166-G174. doi: 10.1152/ajpgi.00315.2020. Epub 2020 Dec 16. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 33325808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,197 results

Search Page

Filters